Premarket small-cap movers include PFAI, BKYI, TCRT, BMBL and SCNI

PFAI reported completing a bench-scale fermentation of recombinant human lactoferrin using methanol-free Pichia fermentation. BKYI added a Middle East government security agency customer; TCRT expanded its leadership team with former Apogee executives; BMBL is to be acquired by Ithaca Holdings; and SCNI signed a $5.1 million development and clinical manufacturing agreement. The source also lists FCHL, AIXI, YJ and WBUY as momentum movers.